Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Whitehawk Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +7 vs. Q3 2025
- Shares held
- 33.0M
- +4.15M (+14.4%) vs. Q3 2025
- Total value
- $79.2M
- +$24.9M (+45.8%) vs. Q3 2025
- New holders
- 12
- 10 more added
- Sold out
- 5
- 6 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 8 | $19 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 19 | $46 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 100 | $242 | 0.00% | +100 | New |
| JPMorgan Chase & Co | 121 | $293 | 0.00% | −300−71.3% | Reduced |
| BNP Paribas Arbitrage, SA | 160 | $387 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 232 | $561 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 386 | $934 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 411 | $995 | 0.00% | +365+793.5% | Added |
| Torren Management, LLC | 1,254 | $3.04K | 0.00% | +1,254 | New |
| Bartlett & Co. Wealth Management LLC | 1,333 | $3.23K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,070 | $7.43K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 3,333 | $8.07K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 6,748 | $16.3K | 0.00% | +4,899+265.0% | Added |
| Quadrature Capital Ltd | 11,447 | $27.7K | 0.00% | +11,447 | New |
| XTX Topco Ltd | 15,704 | $38.0K | 0.00% | −4,076−20.6% | Reduced |
| Prelude Capital Management, LLC | 18,796 | $45.5K | 0.00% | +18,796 | New |
| Acadian Asset Management LLC | 24,634 | $58.0K | 0.00% | −1,572−6.0% | Reduced |
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $64.5K | 100.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 28,641 | $69.3K | 0.00% | −15,474−35.1% | Reduced |
| UBS Group AG | 29,844 | $72.2K | 0.00% | +24,151+424.2% | Added |
| Two Sigma Advisers, LP | 42,400 | $102.6K | 0.00% | +42,400 | New |
| Marshall Wace, LLP | 67,959 | $164.5K | 0.00% | +67,959 | New |
| Jane Street Group, LLC | 69,931 | $169.2K | 0.00% | +44,716+177.3% | Added |
| Qube Research & Technologies Ltd | 72,348 | $175.1K | 0.00% | +72,348 | New |
| ADAR1 Capital Management, LLC | 77,593 | $187.8K | 0.01% | +77,593 | New |
| Citadel Advisors LLC | 98,950 | $239.5K | 0.00% | −41,270−29.4% | Reduced |
| Northern Trust Corp | 103,452 | $250.4K | 0.00% | +31,288+43.4% | Added |
| Susquehanna International Group, LLP | 110,083 | $266.4K | 0.00% | +110,083 | New |
| State Street Corp | 145,537 | $352.2K | 0.00% | +76,800+111.7% | Added |
| Bridgeway Capital Management, LLC | 215,284 | $521.0K | 0.01% | 00.0% | Unchanged |
| Eversept Partners, LP | 260,259 | $629.8K | 0.04% | +260,259 | New |
| BlackRock, Inc. | 299,011 | $723.6K | 0.00% | +2,853+1.0% | Added |
| Two Sigma Investments, LP | 309,865 | $749.9K | 0.00% | +309,865 | New |
| Geode Capital Management, LLC | 425,440 | $1.03M | 0.00% | +43,686+11.4% | Added |
| Renaissance Technologies LLC | 440,722 | $1.07M | 0.00% | −16,700−3.7% | Reduced |
| Ally Bridge Group (NY) LLC | 817,939 | $1.98M | 3.14% | 00.0% | Unchanged |
| Acorn Capital Advisors, LLC | 1,139,363 | $2.76M | 0.93% | 00.0% | Unchanged |
| StemPoint Capital LP | 1,458,807 | $3.53M | 0.61% | +1,034,725+244.0% | Added |
| Vanguard Group Inc | 1,590,117 | $3.85M | 0.00% | +247,210+18.4% | Added |
| Fan Yu | 2,070,000 | $5.01M | 5.43% | 00.0% | Unchanged |
| Siren, L.L.C. | 2,082,000 | $5.04M | 0.15% | 00.0% | Unchanged |
| KVP Capital Advisors, LP | 2,165,997 | $5.24M | 5.41% | +2,165,997 | New |
| Avoro Capital Advisors LLC | 2,849,402 | $6.90M | 0.07% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 3,410,402 | $8.25M | 5.60% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,700,000 | $8.95M | 0.22% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,166,000 | $10.1M | 0.21% | 00.0% | Unchanged |
| QVT Financial LP | 4,615,709 | $10.6M | 1.01% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 0 | $0 | 0.00% | −303,585−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −83,660−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −35,253−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −797−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |